Test Price
2,800 AED✅ Home Collection Available
FLNA Gene Otopaladigital Syndrome Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FLNA لمتلازمة الأذن الحنكية الإصبعية النوع الثاني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – UAE Clinical Excellence
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital‑Grade Home Collection (8 AM‑11 PM) with ISO‑certified cold‑chain transport.
- Clinical Guidance: Complimentary telephonic post‑test interpretation session with DHA‑licensed specialists.
- Insurance & Billing: Direct verification via WhatsApp +971 54 548 8731 (text accepted).
ضمان الدقة: حساسية تشخيصية 99.9% عبر معالجة معتمدة من ISO 9001:2015. خدمة سحب منزلي رفيعة المستوى ونقل مبرد، مع استشارة هاتفية بعد النتيجة لتفسير طبي شامل من أطباء مرخصين من هيئة الصحة بدبي.
Overview
Otopaladigital syndrome type 2 is an X‑linked dominant condition caused by FLNA gene mutations, characterized by skeletal dysplasia and hearing loss. This advanced Next‑Generation Sequencing (NGS) test analyzes the entire FLNA gene to confirm the diagnosis, guide management, and support family planning.
| Feature | Our FLNA NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity; full gene coverage | ~99% accuracy; limited to targeted regions |
| Method | NGS (Illumina® platform) with comprehensive variant detection | Capillary sequencing of defined amplicons |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocol
"As an ENT specialist, I understand how overwhelming a potential genetic diagnosis can be. This NGS test provides the definitive molecular answer you need for personalized care and family counselling. Please ensure any result is integrated with a full clinical evaluation."
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Patient Safety – Exclusion Criteria & Red Flags
- Exclusion: Test cannot be performed if the patient is unwilling or unable to provide consent (guardian consent required for minors under UAE CDS Law 2026).
- Exclusion: Samples with extreme haemolysis or insufficient DNA quantity will be rejected and recollection arranged free of charge.
- Emergency Red Flags: Seek immediate ENT/Orthopedic evaluation if your child develops acute hearing loss, limb deformity progression, or breathing difficulties.
- Mandatory: This test is a diagnostic aid; results must be interpreted by a DHA‑licensed clinical geneticist or ENT surgeon.
Patient FAQ & Clinical Guidance
What is the FLNA gene test for Otopaladigital syndrome type 2 used for?
Clinical Answer: Detects FLNA mutations confirming Otopaladigital syndrome type 2, enabling accurate diagnosis and family planning support.
يكشف هذا الاختبار طفرات جين FLNA لتأكيد متلازمة الأذن الحنكية الإصبعية النوع الثاني، مما يتيح التشخيص الدقيق ودعم التخطيط العائلي.
How is the FLNA genetic performed?
Clinical Answer: A blood or DNA sample is collected at home, then Next‑Generation Sequencing comprehensively analyzes the FLNA gene in our ISO‑certified lab.
يتم جمع عينة دم أو حمض نووي في المنزل، ثم يُحلل جين FLNA بتقنية التسلسل الجيني الشامل (NGS) في مختبرنا المعتمد من ISO.
What is the turnaround time for results?
Clinical Answer: Results are typically ready within 3 to 4 weeks, ensuring meticulous NGS data analysis and a fully verified clinical report.
تصدر النتائج عادةً خلال 3 إلى 4 أسابيع، مما يضمن تحليلًا دقيقًا للبيانات الجينية وتقريرًا سريريًا موثقًا.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians